Price movement over the last 24 hours
Agilent Technologies Inc vs QUALCOMM, Inc. — how do they compare? Agilent Technologies Inc trades at $128.79 (market cap $37.04B), while QUALCOMM, Inc. trades at $186.19 (market cap $192.85B). The key difference: QUALCOMM, Inc. is far larger — about 5.2× Agilent Technologies Inc's market cap, and QUALCOMM, Inc. pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| A | QCOM | |
|---|---|---|
Market Cap | $37.04B | $192.85B |
Sector | Health | Technology |
52-Week High | $157.20 | $251.10 |
52-Week Low | $110.24 | $124.07 |
Enterprise Value | $38.59B | $198.32B |
Dividend Yield | 0.78% | 2.01% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Qualcomm (QCOM) trades at $186.48, up 5.8% in the last 24 hours, reflecting strong momentum. The stock exhibits a bearish technical signal but has consistently beaten earnings expectations in recent quarters. Revenue for 2025 reached $44.28 billion, with a net income margin of 22.31%, though this represents a decline from the previous year. The company is actively diversifying into AI, automotive, and data centers, as highlighted at recent industry events like COMPUTEX 2026.
The outlook is mixed; analyst consensus is a 'Buy' with a $221.21 price target, indicating potential upside, but near-term risks include margin pressures and intense competition in the PC and smartphone chip markets. The stock's valuation, with a P/E of 20.05, appears reasonable relative to growth prospects, but investors must weigh the diversification strategy against persistent market softness.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →